A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.

Key Points: • Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis. • Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working. • Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working. [ABSTRACT FROM AUTHOR]